Table 2.
Formulation | IC50 (μM) | |
---|---|---|
|
||
KB cells | A549 cells | |
DXR solution | 1.20 | 2.17 |
F–PLL-coated liposomal DXR | 30.75 | 104.31 |
PLL-coated liposomal DXR | 64.97 | 105.71 |
Abbreviations: DXR, doxorubicin; F-PLL, folate-poly(L-lysine).
Formulation | IC50 (μM) | |
---|---|---|
|
||
KB cells | A549 cells | |
DXR solution | 1.20 | 2.17 |
F–PLL-coated liposomal DXR | 30.75 | 104.31 |
PLL-coated liposomal DXR | 64.97 | 105.71 |
Abbreviations: DXR, doxorubicin; F-PLL, folate-poly(L-lysine).